(Q24611865)

English

Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

Robert Cook-Deegan

1

0 references

author name string

Christopher DeRienzo

2

0 references

Julia Carbone

3

0 references

Subhashini Chandrasekharan

4

0 references

Christopher Heaney

5

0 references

Christopher Conover

6

0 references

language of work or name

0 references

publication date

April 2010

0 references

Genetics in Medicine

0 references

12

0 references

4 Suppl

0 references

S15-38

0 references

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

7 April 2017

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

7 April 2017

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

7 April 2017

Myriad Genetics: In the eye of the policy storm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

7 April 2017

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Genetic testing for colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Managed care in the genomics era: assessing the cost effectiveness of genetic tests.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Effects of patents and licenses on the provision of clinical genetic testing services

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

AGA technical review on hereditary colorectal cancer and genetic testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

A highly accurate, low cost test for BRCA1 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

27 September 2017

Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

30 May 2018

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

30 May 2018

Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families.

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Factors influencing health insurers' decisions to cover new genetic technologies

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Testing for BRCA1 mutations: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer).

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

The benefits and costs of tamoxifen for breast cancer prevention

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Genetic testing, ethical concerns, and the role of patent law

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A67B

21 January 2018

Couples cull embryos to halt heritage of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Genetic testing, ethical concerns, and the role of patent law

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047448

28 November 2018

Comprehensive cost-utility analysis of newborn screening strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and the UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Writing Effective Insurance Justification Letters for Cancer Genetic Testing: A Streamlined Approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN clinical practice guidelines in oncology. Colorectal cancer screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of financial factors in acceptance of clinical BRCA genetic testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/20393305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/GIM.0B013E3181D5A67B

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24611865&oldid=2175208655"